Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 1
1999 1
2000 2
2001 6
2002 2
2003 7
2004 7
2005 3
2006 8
2007 8
2008 7
2009 4
2010 7
2011 13
2012 6
2013 8
2014 6
2015 5
2016 9
2017 7
2018 8
2019 5
2020 6
2021 4
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 21787195

129 results

Results by year

Filters applied: . Clear all
Page 1
Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
Ikegame K, Yoshihara S, Taniguchi Y, Kaida K, Inoue T, Okada M, Taniguchi K, Hasei H, Tamaki H, Fujioka T, Kato R, Soma T, Ogawa H. Ikegame K, et al. Exp Hematol. 2011 Aug;39(8):880-90. doi: 10.1016/j.exphem.2011.05.007. Epub 2011 May 27. Exp Hematol. 2011. PMID: 21689724 Free article. Clinical Trial.
Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
Bacigalupo A, Sormani MP, Lamparelli T, Gualandi F, Occhini D, Bregante S, Raiola AM, di Grazia C, Dominietto A, Tedone E, Piaggio G, Podesta M, Bruno B, Oneto R, Lombardi A, Frassoni F, Rolla D, Rollandi G, Viscoli C, Ferro C, Garbarino L, Van Lint MT. Bacigalupo A, et al. Haematologica. 2004 Oct;89(10):1238-47. Haematologica. 2004. PMID: 15477210
Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY. Chen XH, et al. Biol Blood Marrow Transplant. 2009 Feb;15(2):266-73. doi: 10.1016/j.bbmt.2008.11.029. Biol Blood Marrow Transplant. 2009. PMID: 19167687 Free article. Clinical Trial.
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.
Levine JE, Uberti JP, Ayash L, Reynolds C, Ferrara JL, Silver SM, Braun T, Yanik G, Hutchinson R, Ratanatharathorn V. Levine JE, et al. Biol Blood Marrow Transplant. 2003 Mar;9(3):189-97. doi: 10.1053/bbmt.2003.50012. Biol Blood Marrow Transplant. 2003. PMID: 12652470 Free article. Clinical Trial.
Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.
Dey BR, McAfee S, Sackstein R, Colby C, Saidman S, Weymouth D, Poliquin C, Vanderklish J, Sachs DH, Sykes M, Spitzer TR. Dey BR, et al. Biol Blood Marrow Transplant. 2001;7(11):604-12. doi: 10.1053/bbmt.2001.v7.pm11760148. Biol Blood Marrow Transplant. 2001. PMID: 11760148 Free article.
129 results